UNITY Biotechnology, Inc. announced the appointment of Margo Roberts, Ph.D. to its board of directors. Dr. Roberts brings to UNITY nearly 30 years of experience in biomedical research. Dr. Roberts has almost three decades of biomedical research experience in both biotechnology and academia. Prior to her tenure at Kite, Dr. Roberts was Principal Scientist and Director of Immune and Cell Therapy at Cell Genesys, Inc. where she led the development and application of CAR technology to T-cells and stem cells, culminating in the very first CAR T-cell clinical trial in 1994.